The history of Viagra, formerly marketed by copyright, presents a fascinating case study for investors considering the pharmaceutical arena . Despite its initial success and creation of billions in revenue , the exclusivity expiration has opened the floodgates for competing medications, significantly reducing profit opportunities. This transition r